Assembly Biosciences, Inc. announced the appointment of Gina Consylman to its board of directors. Ms. Consylman will also serve as a member of Assembly’s Audit Committee. Gina Consylman is a 25-year veteran in the field of accounting, finance, and tax. Currently, Ms. Consylman is senior vice president and chief financial officer at Ironwood Pharmaceuticals, a publicly traded healthcare company, where she leads finance, accounting, tax, investor relations, communications, and corporate strategy and development.